Hello, Thanks for signing up for MarketBeat Daily Ratings—we’re excited to have you on board. Every weekday, you’ll get a curated summary of new “Buy” and “Sell” ratings from Wall Street’s top-rated analysts, the latest stock news, and bonus investing content—all delivered straight to your inbox. You’re just two quick steps away from completing your sign-up: 1. Make sure our emails go to your inbox Gmail users:
Mobile: Tap the three dots (…) in the top right and select Move to Inbox or Move to Primary
Desktop: Click the folder icon at the top and select Move to Inbox or Primary Apple Mail users:
Tap our email address at the top (next to From: on mobile), then select Add to VIP Other providers:
Reply to this message and add newsletters@analystratings.net to your contacts 2. Confirm your subscription Click this link to confirm your subscription. This verifies your account and ensures you receive your newsletters without interruption instead of getting stuck in your spam filter. Confirm your subscription here. After you confirm, feel free to download our popular free report, "7 Stocks to Buy and Hold Forever" with this link. Thanks again for subscribing—we look forward to being part of your investing journey. 
Matthew Paulson
Founder and CEO, MarketBeat. P.S. If you didn’t mean to subscribe, no problem—you can unsubscribe here.
Exclusive Article from MarketBeat Media NANO Nuclear Energy: Short-Squeeze or Rapid Meltdown AheadAuthor: Thomas Hughes. Publication Date: 2/13/2026. 
Key Points - NANO Nuclear Energy is on track for deployment in late 2029 or early 2030.
- Pipeline advances are unlocking access to critical markets in the U.S and Asia.
- Price action is depressed, short interest is high, but analysts indicate deep value, and institutions are accumulating: short-covering and a short squeeze ahead.
- Special Report: [Sponsorship-Ad-6-Format3]
NANO Nuclear Energy (NASDAQ: NNE) is an emerging short-squeeze candidate. The company is among the most-shorted small-cap stocks on the market, and it has a catalyst ahead. The catalyst is the earnings report for the company's fiscal Q1 (FQ1), which is expected to reveal strategic progress on its technology and provide an updated commercialization timeline. (Note that NANO's fiscal reporting period is ahead of the calendar year.) As it stands, the company is progressing steadily and is on track for a late-2029 or early-2030 initial deployment of its micro-modular nuclear reactors. The outlook is bullish and improving, though execution and capital risk remain. Recent news points to pipeline improvement, so the upcoming update is likely to be favorable. The company signed an MOU with South Korea's DS Dansuk Co. to accelerate deployments there and is pursuing a similar agreement in the U.S. The company is also evaluating compatibility between its systems and Ameresco's (NYSE: AMRC) energy infrastructure platforms, potentially unlocking U.S. industrial and government demand. Ameresco is a leading clean-energy provider that helps industries and governments modernize, develop, and operate energy assets. NNE Stock: Short-Sellers Versus Institutions and Analysts Short interest has pulled back from its late-2025 peaks but remains well above healthy levels at about 35%, and it has been largely flat for extended periods. That level of short interest can keep the stock depressed in the absence of a catalyst, and there are no clear signs of covering yet. If that persists, the stock could rebound after the business update but gains may be limited. However, analyst sentiment is solid and institutions are accumulating, which helps limit downside risk. MarketBeat tracks seven analysts covering NANO Nuclear Energy. While not a large panel, it is sufficient to gauge sentiment. The group rates the stock a Moderate Buy: 71% Buy, 14% Sell, and 14% Hold. The price-target range is notable — trading near $25, NNE is roughly 37.5% below the lowest analyst target ahead of the release, suggesting a potential high double-digit upside or better. Institutional activity supports the idea of a price floor and sets the market up for a short squeeze. Institutions own nearly 50% of the stock and have been accumulating since the IPO. Their buying accelerated through 2025 and remained strong in the first six weeks of 2026. MarketBeat's balance shows just over $5 in purchases for every $1 in sales, providing a solid support base and a persistent tailwind for the share price. Dilution Threat Weighs on NNE Share Prices Dilutive share sales pressured NNE shares in 2025 and early 2026. However, the company appears reasonably well-capitalized ahead of its FQ1 2026 report, easing immediate funding concerns. At the F2025 burn rate, the company could continue for more than ten years without additional capital, although spending is likely to ramp in coming years. The regulatory and commercialization process is capital-intensive, and NNE will likely require more funding. The downside is the share count — which was roughly 50% higher at the end of F2025 — may increase further. The upside is that the company carries virtually no liabilities and no long-term debt, leaving future revenue and earnings unencumbered. Price action in NNE stock has been tepid. On weekly charts, indicators point lower, but divergences suggest a bottom may be forming. Critical support sits near the late-2025 low at $23.61 and will likely be tested ahead of the release. If that level fails, a deeper decline — possibly toward $17.50 — could occur. If support holds and a rebound develops, resistance targets are near $30, $35, and $40.
| 
Post a Comment
Post a Comment